Verisante_MSI
1 / 8Pages

Verisante recently announced a breakthrough in the fight against oral and skin cancer with the announcement of a second phase prototype for the Company’s Intelligent Multispectral Imaging Camera. Press releases are short by nature and therefore detailed information is required to be left out. In response to the range of recent queries brought forward, Verisante is issuing a newsletter to clarify the scope of this new product and outline the positive effect it could have on the Company’s future growth. TSX-V: VRS OTCQX: VRSEF

Multispectral Imaging Multispectral imaging (MSI) is a form of imaging that captures data at different frequencies across the electromagnetic spectrum. These frequencies can include wavelengths not visible to the human eye. MSI was originally developed for defense satellite imaging and is now being applied to such varied applications as archeology, forensics, and medical imaging. Verisante MSI Camera Verisante has licensed the exclusive worldwide rights to a rapid MSI imaging system. The camera takes images of 18 different narrow band wavelengths of light in one third of a second to capture...

A Rapid MSI System for Oral and Skin Cancer Current stage • Phase 2 prototype complete (imaging camera for skin cancer) Dr. Haishan Zeng, a distinguished scientist in the Integrative Oncology Department at the BC Cancer Agency and one of the inventors of the MSI camera. Next steps (12-24 months) • Complete laboratory testing for skin cancer prototype • Build 5 additional units to place in the field to gather data for skin cancer device • Develop oral cancer • Build 5 additional units to place in the field to gather data for oral cancer device • Collect user and clinical feedback and engage...

Oral Cancer Statistics The next generation smart diagnostic tool for dentists The American Cancer Society estimates that in 2013: The current worldwide dental equipment market is approximately $5.5 billion and is expected to reach $7 billion in 2018. .6 Source: Transparency Market Research 36,000 / 6,850 people will get oral cavity or oropharyngeal cancer 96 Source: American Cancer Association people will die from these cancers in the United States Early Detection Saves Lives In the United States alone, there is estimated to be 143 million dental office visits per year. Of those patient...

MSI vs Competing Products Current products used in dental offices for oral cancer screening include the Identafi, VELscope and Vizilite systems. Verisante’s MSI System was originally developed at the BC Cancer Agency, and is covered by the company’s Collaborative Research Agreement with the Agency. Verisante’s MSI camera for oral cancer detection has several clear advantages over the products currently on the market. Real Time Imaging Sophisticated Diagnostic Algorithm Billing Code for Procedure The American Dental Association has an approved CDT code (“D0431”) for adjunctive tests intended...

Skin Cancer Statistics Next generation digital dermatoscope and automated diagnostic tool Skin cancer is the most common form of cancer in the world, with the World Health Organization reporting one in every three cancers diagnosed is a skin cancer. The incidence of both nonmelanoma and melanoma skin cancers have been increasing at a rate of approximately 3% per year. One in seven Canadians and one in five Americans will develop skin cancer during their lifetime and over 3.5 million cases (2.5 million people with 3.5 million lesions) of skin cancer are diagnosed annually in the USA. The...

Value Proposition This will be a valuable tool for dermatologists, primary care doctors, and researchers because the images saved will lead to the creation of large data banks. This device can also be a valuable tool for telemedicine to address the absence of dermatologists in small and remote communities. Not only will the device connect to a laptop via USB cable but the Company anticipates development of a companion application for smart phones and tablets where the doctor (or dentist) can enter patient data and save it for serial monitoring, patient files, sharing with colleagues for...

Notes about Forward Looking Statements & Risks and Uncertainties This Newsletter contains certain forward-looking statements. These statements relate to future events or future performance and reflect management’s expectations and assumptions regarding growth, results of operations, performance and business prospects and opportunities. Such forward-looking statements, while they reflect management’s current beliefs and are based on information currently available to management, are, by their nature, based on assumptions and involve known and unknown risks, uncertainties and other factors...